;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Coherus BioSciences amends IPO

    Coherus BioSciences Inc., Redwood City, Calif. Business: Biosimilars Date announced: 2014-10-24 Type: IPO To be raised: Up to $94.4 million Shares: 6.3 million Price: $12-$15 Underwriters: JPMorgan; Credit Suisse; Cowen…

    Published on 10/27/2014
  • S1 Biopharma amends IPO

    S1 Biopharma Inc., New York, N.Y. Business: Genitourinary Date announced: 2014-10-22 Type: IPO To be raised: Up to $38.5 million Shares: 2.8 million Price: $12-$14 Underwriter: MLV Overallotment: 412,500 Note: The …

    Published on 10/27/2014
  • Tobira amends IPO

    Tobira Therapeutics Inc., San Francisco, Calif. Business: Infectious Date announced: 2014-10-21 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Oppenheimer Note: The company amended its IPO on NASDAQ, …

    Published on 10/27/2014
  • Auspherix completes venture financing

    Auspherix Pty. Ltd., Sydney, Australia Business: Infectious Date completed: 2014-10-23 Type: Venture financing Raised: A$1 million ($876,000) Investor: Medical Research Commercialization Fund

    Published on 10/27/2014
  • Celator completes follow-on

    Celator Pharmaceuticals Inc. (NASDAQ:CPXX), Ewing, N.J. Business: Cancer Date completed: 2014-10-23 Type: Follow-on Raised: $12.9 million Units: 6.6 million Price: $1.95 (unit) Shares after offering: 32.7 million …

    Published on 10/27/2014
  • Check-Cap completes venture financing

    Check-Cap Ltd., Isfiya, Israel Business: Diagnostic Date completed: 2014-10-19 Type: Venture financing Raised: Not disclosed Investors: Fosun Pharma; GE Ventures; Pontifax; Docor International; Counterpoint; MNS; and …

    Published on 10/27/2014
  • Critical Outcome Technologies completes private placement of units

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 2014-10-17 Type: Private placement of units Raised: $462,921 Units: 2 million Price:…

    Published on 10/27/2014
  • DBV completes follow-on

    DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT), Bagneux, France Business: Inflammation, Diagnostic Date completed: 2014-10-22 Type: Follow-on Raised: $106.5 million Shares: 4.9 million Price: $21.64 Shares after …

    Published on 10/27/2014
  • DBV completes private placement

    DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT), Bagneux, France Business: Inflammation, Diagnostic Date completed: 2014-10-22 Type: Private placement Raised: EUR20.9 million ($26.7 million) Shares: 614,937 Price: …

    Published on 10/27/2014
  • Encoded Genomics completes venture financing

    Encoded Genomics Inc., San Francisco, Calif. Business: Genomics Date completed: 2014-10-15 Type: Venture financing Raised: $100,000 Investor: Illumina Inc. Note: The offering comprises convertible notes. The company …

    Published on 10/27/2014
  • EpiBiome completes venture financing

    EpiBiome Inc., San Francisco, Calif. Business: Veterinary Date completed: 2014-10-15 Type: Venture financing Raised: $100,000 Investor: Illumina Inc. Note: The offering comprises convertible notes. The company also has …

    Published on 10/27/2014
  • Erytech completes private placement

    Erytech Pharma S.A. (Euronext:ERYP), Lyon, France Business: Cancer, Endocrine/Metabolic, Hematology Date completed: 2014-10-23 Type: Private placement Raised: EUR30 million ($38.2 million) Shares: 1.2 million Price: …

    Published on 10/27/2014
  • Forendo Pharma completes venture financing

    Forendo Pharma Oy, Turku, Finland Business: Genitourinary, Endocrine/Metabolic Date completed: 2014-10-22 Type: Venture financing Raised: EUR3 million ($3.8 million) Investors: Novartis Venture Funds; MS Ventures; …

    Published on 10/27/2014
  • HealthTell completes venture financing

    HealthTell Inc., San Ramon, Calif. Business: Diagnostic Date completed: 2014-10-21 Type: Venture financing Raised: $13.5 million Investors: Paladin Capital; Vital Venture Capital; Acadia Woods Partners; Cambridge Global…

    Published on 10/27/2014
  • ImmuPharma completes private placement

    ImmuPharma plc (LSE:IMM), London, U.K. Business: Autoimmune, Neurology, Infectious Date completed: 2014-10-21 Type: Private placement Raised: L3.4 million ($5.4 million) Shares: 6.3 million Price: 53p Shares after …

    Published on 10/27/2014
  • Nanosphere completes follow-on

    Nanosphere Inc. (NASDAQ:NSPH), Northbrook, Ill. Business: Diagnostic Date completed: 2014-10-22 Type: Follow-on Raised: $20 million Shares: 40 million Price: $0.50 Shares after offering: 116.9 million Underwriter: …

    Published on 10/27/2014
  • Probiodrug completes IPO

    Probiodrug AG (Euronext:PBD), Halle/Saale, Germany Business: Neurology, Autoimmune, Inflammation Date completed: 2014-10-23 Type: IPO Raised: EUR22.5 million ($28.7 million) Shares: 1.5 million Price: EUR15.25 Shares …

    Published on 10/27/2014
  • Proteon completes IPO

    Proteon Therapeutics Inc. (NASDAQ:PRTO), Waltham, Mass. Business: Cardiovascular Date completed: 2014-10-21 Type: IPO Raised: $61.1 million Shares: 6.1 million Price: $10 Shares after offering: 15 million Underwriters: …

    Published on 10/27/2014
  • Quartet Medicine completes venture financing

    Quartet Medicine, Cambridge, Mass. Business: Neurology, Inflammation Date completed: 2014-10-23 Type: Venture financing Raised: $17 million Investors: Atlas Ventures; Novartis Venture Funds; Pfizer Venture Investments; …

    Published on 10/27/2014
  • Relmada completes warrant exercise

    Relmada Therapeutics Inc. (OTCBB:RLMD), New York, N.Y. Business: Neurology Date completed: 2014-10-16 Type: Warrant exercise Raised: $15.2 million Shares: 10.1 million Price: $1.50 Shares after offering: 50.4 million …

    Published on 10/27/2014
  • Sequenta completes venture financing

    Sequenta Inc., San Francisco, Calif. Business: Diagnostic Date completed: 2014-10-20 Type: Venture financing Raised: Not disclosed Investors: Celgene Corp.; and other undisclosed investors Note: The amount raised was …

    Published on 10/27/2014
  • Transgenomic completes private placement of common stock and warrants

    Transgenomic Inc. (NASDAQ:TBIO), Omaha, Neb. Business: Supply/Service Date completed: 2014-10-22 Type: Private placement of common stock and warrants Raised: $2.4 million Shares: 730,776 Price: $3.25 Shares after …

    Published on 10/27/2014
  • Unum Therapeutics completes venture financing

    Unum Therapeutics Inc., Cambridge, Mass. Business: Cancer Date completed: 2014-10-21 Type: Venture financing Raised: $12 million Investors: Fidelity Biosciences; Atlas Ventures; Sanofi-Genzyme BioVentures

    Published on 10/27/2014
  • Viamet completes venture financing

    Viamet Pharmaceuticals Inc., Durham, N.C. Business: Infectious, Cancer Date completed: 2014-10-21 Type: Venture financing Raised: $60 million Investors: Brandon Point Industries; Woodford Investment Management

    Published on 10/27/2014
  • Xcell Biosciences completes venture financing

    Xcell Biosciences Inc., San Francisco, Calif. Business: Diagnostic Date completed: 2014-10-15 Type: Venture financing Raised: $100,000 Investor: Illumina Inc. Note: The offering comprises convertible notes. The company …

    Published on 10/27/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993